US$ 22.21
retatrutide delivery 20mg Research Peptide Medscape | Retatrutide, Eli Lilly's
Description
It combines fiber principles with appetite-regulating botanicals and nutrients, addressing both gut and metabolic pathways simultaneously
This novel strategy targeting the CB1 receptor is a logical advancement following the promising outcomes in early trials," commented Harold Edward Bays, MD, Medical Director/President of Louisville Metabolic and Atherosclerosis Research Center/Your Body Goal

Current status: Investigational medicine in Phase 3 trials

fda.gov Eli Lilly Press Release

If not, contact your prescribing provider and pharmacy

For 503B outsourcing facilities, the cutoff was May 22, 2025
